Cargando…
Clinical Implications of Atrial Fibrillation Detection Using Wearable Devices in Patients With Cryptogenic Stroke (CANDLE-AF) Trial: Design and Rationale
BACKGROUND: Although many electrocardiography wearable devices have been released recently for the detection of atrial fibrillation (AF), there are few studies reporting prospective data for wearable devices compared to the strategy of the existing guidelines in the detection of atrial fibrillation...
Autores principales: | Jung, Sodam, Lee, Hye Ah, Kang, In Sook, Shin, Sang Hoon, Chang, Yoonkyung, Woo Shin, Dong, Park, Moo-Seok, Kim, Young Dae, Nam, Hyo Suk, Heo, Ji Hoe, Kim, Tae-Hoon, Yu, Hee Tae, Lee, Jung Myung, Heo, Sung Hyuk, Woo, Ho Geol, Park, Jin-Kyu, Roh, Seung-Young, Kim, Chi Kyung, Lee, Young-Soo, Do, Jin Kuk, Kim, Dong-Hyeok, Song, Tae-Jin, Park, Junbeom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013795/ https://www.ncbi.nlm.nih.gov/pubmed/35445088 http://dx.doi.org/10.3389/fcvm.2022.837958 |
Ejemplares similares
-
Corrigendum: Clinical implications of atrial fibrillatioN detection using wearabLE devices in patients with cryptogenic stroke (CANDLE-AF) trial: Design and rationale
por: Jung, Sodam, et al.
Publicado: (2023) -
Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)
por: Park, Junbeom, et al.
Publicado: (2022) -
Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
por: Park, Hanjin, et al.
Publicado: (2023) -
A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
por: Kim, Hyeongsoo, et al.
Publicado: (2020) -
A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry
por: Kim, Hyeongsoo, et al.
Publicado: (2017)